Navigation Links
Novogen Announces Presentation at Rodman & Renshaw 16th Annual Healthcare Conference
Date:9/3/2014

SYDNEY, Sept. 3, 2014 /PRNewswire/ -- Novogen Ltd. (ASX: NRT, NASDAQ: NVGN) today announced that Graham Kelly PhD, CEO, will present at the Rodman & Renshaw 16th Annual Healthcare Conference on Wednesday, September 10th in New York.  Dr. Kelly will provide an overview of the two Novogen first-in-class drug technology platforms in the field of oncology.  His presentation will take place at the New York Palace Hotel and will begin at 10:25am.

About Novogen LimitedNovogen is a public, Australian drug-development company whose shares trade on both the Australian Securities Exchange ('NRT') and NASDAQ ('NVGN'). The Novogen Group includes a New Haven CT-based joint venture company, CanTx Inc, with Yale University.

Novogen has two main drug technology platforms: super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). SBP compounds have been created to kill the full range of cells within a tumor, but particularly the cancer stem cells. The ATM compounds target the microfilament component of the cancer cell and when used in conjunction with standard anti-microtubular drugs, result in comprehensive and fatal destruction of the cancer cell's cytoskeleton. Ovarian cancer, colorectal cancer, malignant ascites, prostate cancer, neural cancers (glioblastoma, neuroblastoma) and melanoma are the key clinical indications being pursued, with the ultimate objective of employing both technologies as a unified approach to first-line therapy.

Further information is available on the Company's website, www.novogen.com.

For more information please contact:Corporate ContactMedia enquiriesExecutive Chairman & CEO
Novogen Group
Graham.Kelly@novogen.com 
+61 (0) 2 9472 4100In the USA:Lazar Partners
Novogen@lazarpartners.com 
+1 212-867-1762Investors enquiriesIn Australia:In the USA:Lazar Partners

Novogen@lazarpartners.com

+1 212-867-1762

Dr. Douglas Pretsell

Instinctif Partners

+61 (0) 3 9657 0706In ROW:Sue Charles

Instinctif Partners

+44 (0) 20 7457 2020Logo - http://photos.prnewswire.com/prnh/20131220/NY36990LOGO 


'/>"/>
SOURCE Novogen Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Novogen Announces Results of General Meeting of Shareholders
2. Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy
3. Top Active Companies to Watch: Crown Marketing, Herbalife, Novogen, GNC, Pfizer and Infinity Pharmaceuticals
4. Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares
5. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
6. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
7. Ascendant Solutions, Inc. Announces Completion of Second Pharmacy Acquisition by Its Doughertys Holdings Subsidiary
8. Integrity Applications, Inc. Announces Equity Financing of $3.0 Million
9. GenSpera Announces Generic Name "Mipsagargin" for Lead Drug Candidate G-202 per Recommendation by World Health Organization
10. Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections
11. MarketResearch.com Announces Addition of New Kalorama Information Content to Diagnostics Knowledge Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
Breaking Medicine News(10 mins):